Cargando…
Injectable Hydrogel for Cu(2+) Controlled Release and Potent Tumor Therapy
Disulfiram (DSF) is an important drug for the treatment and management of alcohol dependency. This drug has been approved by US-FDA, and its activity against the tumor is dependent on copper ion (Cu(2+)). However, the copper toxicity (caused via external copper) and its intrinsic anfractuous distrib...
Autores principales: | Huang, Chunyu, Chen, Bei, Chen, Mingzhu, Jiang, Wei, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147102/ https://www.ncbi.nlm.nih.gov/pubmed/33925834 http://dx.doi.org/10.3390/life11050391 |
Ejemplares similares
-
Injectable Hydrogel for NIR-II Photo-Thermal Tumor Therapy and Dihydroartemisinin-Mediated Chemodynamic Therapy
por: Chen, Danyang, et al.
Publicado: (2020) -
Nanozyme hydrogel for enhanced alkyl radical generation and potent antitumor therapy
por: Ning, Shipeng, et al.
Publicado: (2022) -
Injectable Hydrogel System for Camptothecin Initiated Nanocatalytic Tumor Therapy With High Performance
por: Wang, Shuntao, et al.
Publicado: (2022) -
Injectable Hydrogel for Synergetic Low Dose Radiotherapy, Chemodynamic Therapy and Photothermal Therapy
por: Chen, Mingzhu, et al.
Publicado: (2021) -
Microfluidic Synthesis of the Tumor Microenvironment-Responsive Nanosystem for Type-I Photodynamic Therapy
por: Huang, Chunyu, et al.
Publicado: (2022)